AI stocks split before the bell as Nvidia gets a fresh memory-supply signal and Microsoft nears earnings
26 January 2026
1 min read

AI stocks split before the bell as Nvidia gets a fresh memory-supply signal and Microsoft nears earnings

New York, Jan 26, 2026, 06:12 EST — Premarket

Nvidia shares climbed in early trading Monday following a Reuters report that Samsung Electronics will begin producing its next-generation high-bandwidth memory chips, HBM4, next month to supply the AI chipmaker. 1

This read-through is crucial since memory poses a tough bottleneck for high-end AI processors: if there isn’t enough fast memory, the chips starve. HBM (high-bandwidth memory), a stacked DRAM built for this exact purpose, has faced shortages that quietly cap how fast data centers can scale their AI capacity.

The supply headline hits at a tricky time for traders. With a packed week of big-tech earnings looming, attention is zeroing in on just a couple of key points: AI revenue growth and the extent of any capex increases.

Microsoft jumped 3.3% in early trading, Nvidia climbed 1.5%, and AMD added 2.3%. On the downside, Broadcom dropped 1.7%, with Arm sliding 2.6%. Palantir edged up 2.3%, Micron gained 0.5%, but chip ETFs struggled—SOXX fell 1.1% and SMH dropped 0.7%.

Samsung is pushing to catch up with SK Hynix, a crucial provider of advanced memory chips for Nvidia’s AI accelerators, following supply hiccups that dented its earnings and weighed on its stock. 2

Micron faces a double-edged sword: a rival narrowing the gap with Nvidia poses a threat, yet supply remains constrained. “Micron’s HBM supply for 2026 is already sold out,” noted William Blair analyst Sebastien Naji, who also projects Micron will maintain a low-20% market share through 2027. 3

Microsoft, a key indicator of AI demand via Azure and its software suite, is set to release its fiscal second-quarter results after markets close on Jan. 28. CEO Satya Nadella and CFO Amy Hood will head up the earnings call. 4

UBS trimmed its Microsoft price target to $600 from $650 but stayed bullish with a buy rating, citing a broader de-rating in software stocks. Some analysts are growing more cautious on valuations despite holding onto positive ratings. 5

The scene isn’t straightforward. Late Sunday, U.S. index futures dipped as traders mulled over renewed tariff discussions and a growing chance of a government shutdown in Washington. On top of that, the earnings slate is crowded with major tech giants. 6

The risk is clear: if this week’s earnings reveal AI demand growing more slowly than anticipated, or if firms pull back on capex, the top AI stocks with the highest multiples could face more volatile moves. Bill Gates, speaking at Davos, cautioned that not every company benefiting from the AI surge will justify its lofty valuations—a sharp reminder that this trade isn’t one-sided. 7

Investors are focused on a clear, upcoming event: Microsoft’s earnings release on Wednesday. Other major tech companies will report later in the week, offering insight into AI spending and whether revenue growth is keeping pace. 8

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Fed week starts: U.S. stock futures dip as Big Tech earnings loom and gold hits new record
Previous Story

Fed week starts: U.S. stock futures dip as Big Tech earnings loom and gold hits new record

Silver price breaks $110 to a record as dollar slides on intervention talk and Fed focus
Next Story

Silver price breaks $110 to a record as dollar slides on intervention talk and Fed focus

Go toTop